121 related articles for article (PubMed ID: 24975961)
1. Cardiovascular risk in patients with small and medium abdominal aortic aneurysms, and no history of cardiovascular disease.
Sohrabi S; Wheatcroft S; Barth JH; Bailey MA; Johnson A; Bridge K; Griffin K; Baxter PD; Scott DJ
Br J Surg; 2014 Sep; 101(10):1238-43. PubMed ID: 24975961
[TBL] [Abstract][Full Text] [Related]
2. Abdominal aortic aneurysms, or a relatively large diameter of non-aneurysmal aortas, increase total and cardiovascular mortality: the Tromsø study.
Forsdahl SH; Solberg S; Singh K; Jacobsen BK
Int J Epidemiol; 2010 Feb; 39(1):225-32. PubMed ID: 19897467
[TBL] [Abstract][Full Text] [Related]
3. C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations.
Burger PM; Pradhan AD; Dorresteijn JAN; Koudstaal S; Teraa M; de Borst GJ; van der Meer MG; Mosterd A; Ridker PM; Visseren FLJ;
Am J Cardiol; 2023 Jun; 197():13-23. PubMed ID: 37218417
[TBL] [Abstract][Full Text] [Related]
4. Abdominal aortic aneurysms, increasing infrarenal aortic diameter, and risk of total mortality and incident cardiovascular disease events: 10-year follow-up data from the Cardiovascular Health Study.
Freiberg MS; Arnold AM; Newman AB; Edwards MS; Kraemer KL; Kuller LH
Circulation; 2008 Feb; 117(8):1010-7. PubMed ID: 18268154
[TBL] [Abstract][Full Text] [Related]
5. Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease.
Beysel S; Kizilgul M; Ozbek M; Caliskan M; Kan S; Apaydin M; Ozcelik O; Cakal E
Clin Interv Aging; 2017; 12():2063-2068. PubMed ID: 29255351
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department: a retrospective cohort study.
Yoshinaga R; Doi Y; Ayukawa K; Ishikawa S
BMJ Open; 2017 Oct; 7(10):e015112. PubMed ID: 28988163
[TBL] [Abstract][Full Text] [Related]
7. Combined Cathepsin S and hs-CRP predicting inflammation of abdominal aortic aneurysm.
Qin Y; Yang Y; Liu R; Cao X; Liu O; Liu J; Wang M; Yang Y; Chen Z; Zhang H; Du J
Clin Biochem; 2013 Aug; 46(12):1026-1029. PubMed ID: 23742758
[TBL] [Abstract][Full Text] [Related]
8. Fatty Acid Binding Protein-4 and Risk of Cardiovascular Disease: The Cardiovascular Health Study.
Egbuche O; Biggs ML; Ix JH; Kizer JR; Lyles MF; Siscovick DS; Djoussé L; Mukamal KJ
J Am Heart Assoc; 2020 Apr; 9(7):e014070. PubMed ID: 32248728
[TBL] [Abstract][Full Text] [Related]
9. Endovascular aneurysm repair at 5 years: Does aneurysm diameter predict outcome?
Zarins CK; Crabtree T; Bloch DA; Arko FR; Ouriel K; White RA
J Vasc Surg; 2006 Nov; 44(5):920-29; discussion 929-31. PubMed ID: 17098519
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein polymorphism rs3091244 is associated with abdominal aortic aneurysm.
Saratzis A; Bown M; Wild B; Sayers RD; Nightingale P; Smith J; Johnson C; Kitas G
J Vasc Surg; 2014 Nov; 60(5):1332-1339. PubMed ID: 24135623
[TBL] [Abstract][Full Text] [Related]
11. Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study.
Chow WS; Tso AW; Xu A; Yuen MM; Fong CH; Lam TH; Lo SV; Tse HF; Woo YC; Yeung CY; Cheung BM; Lam KS
J Am Heart Assoc; 2013 Jan; 2(1):e004176. PubMed ID: 23525430
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm.
Robertson L; Atallah E; Stansby G
Cochrane Database Syst Rev; 2014 Jan; (1):CD010447. PubMed ID: 24449038
[TBL] [Abstract][Full Text] [Related]
13. Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of C-reactive protein plasma levels.
De Haro J; Acin F; Bleda S; Varela C; Medina FJ; Esparza L
J Vasc Surg; 2012 Jul; 56(1):45-52. PubMed ID: 22551908
[TBL] [Abstract][Full Text] [Related]
14. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of cardiovascular disease and cardiovascular death in patients with a small abdominal aortic aneurysm.
Bath MF; Gokani VJ; Sidloff DA; Jones LR; Choke E; Sayers RD; Bown MJ
Br J Surg; 2015 Jul; 102(8):866-72. PubMed ID: 25974255
[TBL] [Abstract][Full Text] [Related]
16. Life expectancy and causes of death after repair of intact and ruptured abdominal aortic aneurysms.
Bastos Gonçalves F; Ultee KH; Hoeks SE; Stolker RJ; Verhagen HJ
J Vasc Surg; 2016 Mar; 63(3):610-6. PubMed ID: 26553951
[TBL] [Abstract][Full Text] [Related]
17. Cancer Incidence After Diagnosis of Abdominal Aortic Aneurysm-Brief Report.
Luo L; Haas AM; Bell CF; Baylis RA; Adkar SS; Fu C; Angelov I; Giordano SH; Klarin D; Leeper NJ; Nead KT
Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1694-1701. PubMed ID: 38779853
[TBL] [Abstract][Full Text] [Related]
18. Aortic aneurysms secrete interleukin-6 into the circulation.
Dawson J; Cockerill GW; Choke E; Belli AM; Loftus I; Thompson MM
J Vasc Surg; 2007 Feb; 45(2):350-6. PubMed ID: 17264016
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm.
Bahia SS; Vidal-Diez A; Seshasai SR; Shpitser I; Brownrigg JR; Patterson BO; Ray KK; Holt PJ; Thompson MM; Karthikesalingam A
Br J Surg; 2016 Nov; 103(12):1626-1633. PubMed ID: 27704527
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Abdominal Aortic Aneurysm on Cardiovascular Diseases.
Ko KJ; Yoo JH; Cho HJ; Kim MH; Jun KW; Han KD; Hwang JK
Int Heart J; 2021; 62(6):1235-1240. PubMed ID: 34853219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
